Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients

Pharmacotherapy

Volumn 26, Issue 10, 2006, Pages 1433-1437

  Corman, Shelby L ^a,c   Coley, Kim C ^a   Schonder, Kristine S ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c 302 Scaife Hall ^*  (United States)

Author keywords

FK506; Liver transplant; Nephrotoxicity; Renal function; Tacrolimus; Transplantation

Indexed keywords

CREATININE; TACROLIMUS;

ADULT; AGE; ALCOHOL LIVER CIRRHOSIS; ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OUTCOME ASSESSMENT; RACE; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; TREATMENT INDICATION; UNIVERSITY HOSPITAL;

ACUTE DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS; TIME FACTORS; TRANSPLANTATION;

EID: 33749492165     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.10.1433     Document Type: Article

References (16)

1. Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving ≥ 5 years after liver transplant. Transplantation 2000;69:781-9.
2. Moutabarrik A, Ishibashi M, Bukunaga M, et al. FK506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells. Transplant Int 1992;5(suppl 1):S93-7.
3. Haller M, Schonfelder R, Breigel J, et al. Renal function in the postoperative period after orthotopic liver transplantation. Transplant Proc 1992;24:2704-6.
4. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-15.
5. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy. Transplantation 2001;72: 1934-9.
6. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM. Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation 1998;66:59-66.
7. Jain A, Marcos A, Reyes J, et al. Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. Transplant Proc 2005;37:1207-10.
8. Ziolkowski J, Paczek L, Senatorski G, et al. Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transplant Proc 2003;35:2307-9.
9. Mor E, Patel T, Glabman S, et al. Comparison of short and long-term renal function in liver transplant patients receiving cyclosporine or FK 506. Transplant Int 1994;7(suppl 1):S77-80.
10. O'Grady JG, Burroughs A, Hardy P, Elbourne D, Truesdale A. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomized controlled trial. Lancet 2002;360:1119-25.
11. Platz KP, Mueller AR, Blumhardt G, et al. Nephrotoxicity following orthotopic liver transplantation. Transplantation 1994;58:170-8.
12. Platz KP, Mueller AR, Blumhardt G, et al. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. Transpl Int 1994;7(suppl 1):S52-7.
13. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine [abstr]. J Am Soc Nephrol 2000;11:A0828.
14. National Kidney Foundation. K/DOQ1 clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:Sl-266.
15. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-40.
16. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the modification of diet in renal disease study. Kidney Int 1997;51:1908-19.